Received Oct 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | G79C4 | — |
A nurse reported that a n infant patient received an expired dose of Havrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 13-month-old male patient who received HAV (Havrix) (batch number G79C4, expiry date 20-SEP-2025) for prophylaxis. On 24-SEP-2025, the patient received Havrix. On 24-SEP-2025, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: A nurse reported that a n infant patient received an expired dose of Havrix). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 24 SEP 2025 A nurse reported that on the day of reporting, an infant patient received an expired dose of Havrix. The reporter asked if this dose was valid or not.